0001541157-13-000002.txt : 20130930 0001541157-13-000002.hdr.sgml : 20130930 20130930154511 ACCESSION NUMBER: 0001541157-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20130930 DATE AS OF CHANGE: 20130930 EFFECTIVENESS DATE: 20130930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celsus Therapeutics Plc. CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-203753 FILM NUMBER: 131123207 BUSINESS ADDRESS: STREET 1: 53 DAVIES STREET CITY: LONDON STATE: X0 ZIP: W1K 5JH BUSINESS PHONE: 646-878-0804 MAIL ADDRESS: STREET 1: C/O MARK COHEN, CHAIRMAN, PEARL COHEN STREET 2: 1500 BROADWAY, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 D 1 primary_doc.xml X0707 D LIVE 0001541157 Celsus Therapeutics Plc. 53 DAVIES STREET LONDON X0 UNITED KINGDOM W1K 5JH +44-207-152-6341 UNITED KINGDOM Morria Biopharmaceuticals PLC Corporation true Gur Roshwalb c/o Celsus Therapeutics Plc 53 Davies Street London X0 UNITED KINGDOM W1K 5JH Executive Officer Chief Executive Officer Dov Elefant c/o Celsus Therapeutics Plc 53 Davies Street London X0 UNITED KINGDOM W1K 5JH Executive Officer Saul Yedgar Department of Biochemistry Hebrew University-Hadassah Med. School Jerusalem L3 ISRAEL 91120 Executive Officer Director Mark Cohen Pearl Cohen Zedek Latzer, LLP 1500 Broadway, 12th Floor New York NY NEW YORK 10036 Director Johnson Lau 701 Ellicott Street Buffalo NY NEW YORK 14203 Director David Sidransky c/o Celsus Therapeutics Plc 53 Davies Street London X0 UNITED KINGDOM W1K 5JH Director Amos Eiran 2 Avner Street Herzeliya L3 ISRAEL 46662 Director Alan Harris 190 East 72nd Street, Apt. 32C New York NY NEW YORK 10021 Executive Officer Robert Doman c/o Celsus Therapeutics Plc 53 Davies Street London X0 UNITED KINGDOM W1K 5JH Director Fredric Price c/o Celsus Therapeutics Plc 53 Davies Street London X0 UNITED KINGDOM W1K 5JH Director Biotechnology No Revenues 06c false 2013-09-24 false true false 0 MTS Securities, LLC 104059 None None 623 Fifth Avenue, 14th Floor New York NY NEW YORK 10022 CA CALIFORNIA FL FLORIDA NJ NEW JERSEY NY NEW YORK false Oppenheimer & Co. Inc. 249 None None 125 Broad Street, 16th Floor New York NY NEW YORK 10004 CA CALIFORNIA FL FLORIDA NJ NEW JERSEY NY NEW YORK false 12516232 12516232 0 false 18 876136 0 MTS Securities, LLC served as lead placement agent and Oppenheimer & Co. acted as co-placement agent for the Issuer. 180000 true For back pay and reimbursement of expenses for officers. false Celsus Therapeutics Plc. /s/ Dov Elefant Dov Elefant Chief Financial Officer 2013-09-30